Copyright Reports & Markets. All rights reserved.

Global Knee Osteoarthritis Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Non-surgical Treatment
    • 1.2.3 Surgical Treatment
  • 1.3 Market by Application
    • 1.3.1 Global Knee Osteoarthritis Treatment Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Ambulatory Surgical Centers
    • 1.3.4 Specialty Clinics
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Knee Osteoarthritis Treatment Market Perspective (2015-2026)
  • 2.2 Global Knee Osteoarthritis Treatment Growth Trends by Regions
    • 2.2.1 Knee Osteoarthritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Knee Osteoarthritis Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Knee Osteoarthritis Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Knee Osteoarthritis Treatment Players by Market Size
    • 3.1.1 Global Top Knee Osteoarthritis Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2015-2020)
  • 3.2 Global Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Knee Osteoarthritis Treatment Revenue
  • 3.4 Global Knee Osteoarthritis Treatment Market Concentration Ratio
    • 3.4.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Knee Osteoarthritis Treatment Revenue in 2019
  • 3.5 Key Players Knee Osteoarthritis Treatment Area Served
  • 3.6 Key Players Knee Osteoarthritis Treatment Product Solution and Service
  • 3.7 Date of Enter into Knee Osteoarthritis Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Knee Osteoarthritis Treatment Breakdown Data by Type (2015-2026)

  • 4.1 Global Knee Osteoarthritis Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2021-2026)

5 Knee Osteoarthritis Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2015-2020)
  • 5.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Knee Osteoarthritis Treatment Market Size (2015-2026)
  • 6.2 North America Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
  • 6.3 North America Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
  • 6.4 North America Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Knee Osteoarthritis Treatment Market Size (2015-2026)
  • 7.2 Europe Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
  • 7.3 Europe Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
  • 7.4 Europe Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Knee Osteoarthritis Treatment Market Size (2015-2026)
  • 8.2 China Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
  • 8.3 China Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
  • 8.4 China Knee Osteoarthritis Treatment Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Knee Osteoarthritis Treatment Market Size (2015-2026)
  • 9.2 Japan Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
  • 9.3 Japan Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
  • 9.4 Japan Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Knee Osteoarthritis Treatment Market Size (2015-2026)
  • 10.2 Southeast Asia Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Bioventus
    • 11.1.1 Bioventus Company Details
    • 11.1.2 Bioventus Business Overview
    • 11.1.3 Bioventus Knee Osteoarthritis Treatment Introduction
    • 11.1.4 Bioventus Revenue in Knee Osteoarthritis Treatment Business (2015-2020))
    • 11.1.5 Bioventus Recent Development
  • 11.2 AVM Biotechnology
    • 11.2.1 AVM Biotechnology Company Details
    • 11.2.2 AVM Biotechnology Business Overview
    • 11.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Introduction
    • 11.2.4 AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.2.5 AVM Biotechnology Recent Development
  • 11.3 Anika Therapeutics
    • 11.3.1 Anika Therapeutics Company Details
    • 11.3.2 Anika Therapeutics Business Overview
    • 11.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Introduction
    • 11.3.4 Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.3.5 Anika Therapeutics Recent Development
  • 11.4 Flexion Therapeutics
    • 11.4.1 Flexion Therapeutics Company Details
    • 11.4.2 Flexion Therapeutics Business Overview
    • 11.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Introduction
    • 11.4.4 Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.4.5 Flexion Therapeutics Recent Development
  • 11.5 OrthoTrophix
    • 11.5.1 OrthoTrophix Company Details
    • 11.5.2 OrthoTrophix Business Overview
    • 11.5.3 OrthoTrophix Knee Osteoarthritis Treatment Introduction
    • 11.5.4 OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.5.5 OrthoTrophix Recent Development
  • 11.6 Sanofi
    • 11.6.1 Sanofi Company Details
    • 11.6.2 Sanofi Business Overview
    • 11.6.3 Sanofi Knee Osteoarthritis Treatment Introduction
    • 11.6.4 Sanofi Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.6.5 Sanofi Recent Development
  • 11.7 Horizon Therapeutics
    • 11.7.1 Horizon Therapeutics Company Details
    • 11.7.2 Horizon Therapeutics Business Overview
    • 11.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Introduction
    • 11.7.4 Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.7.5 Horizon Therapeutics Recent Development
  • 11.8 Johnson and Johnson
    • 11.8.1 Johnson and Johnson Company Details
    • 11.8.2 Johnson and Johnson Business Overview
    • 11.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Introduction
    • 11.8.4 Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.8.5 Johnson and Johnson Recent Development
  • 11.9 GlaxoSmithKline
    • 11.9.1 GlaxoSmithKline Company Details
    • 11.9.2 GlaxoSmithKline Business Overview
    • 11.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Introduction
    • 11.9.4 GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.9.5 GlaxoSmithKline Recent Development
  • 11.10 Bayer
    • 11.10.1 Bayer Company Details
    • 11.10.2 Bayer Business Overview
    • 11.10.3 Bayer Knee Osteoarthritis Treatment Introduction
    • 11.10.4 Bayer Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 11.10.5 Bayer Recent Development
  • 11.11 Abbott
    • 10.11.1 Abbott Company Details
    • 10.11.2 Abbott Business Overview
    • 10.11.3 Abbott Knee Osteoarthritis Treatment Introduction
    • 10.11.4 Abbott Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 10.11.5 Abbott Recent Development
  • 11.12 Pfizer
    • 10.12.1 Pfizer Company Details
    • 10.12.2 Pfizer Business Overview
    • 10.12.3 Pfizer Knee Osteoarthritis Treatment Introduction
    • 10.12.4 Pfizer Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 10.12.5 Pfizer Recent Development
  • 11.13 Eli Lilly
    • 10.13.1 Eli Lilly Company Details
    • 10.13.2 Eli Lilly Business Overview
    • 10.13.3 Eli Lilly Knee Osteoarthritis Treatment Introduction
    • 10.13.4 Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
    • 10.13.5 Eli Lilly Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Knee Osteoarthritis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Knee Osteoarthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Non-surgical Treatment
    Surgical Treatment

    Market segment by Application, split into
    Hospitals
    Ambulatory Surgical Centers
    Specialty Clinics
    Others

    Based on regional and country-level analysis, the Knee Osteoarthritis Treatment market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Knee Osteoarthritis Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Bioventus
    AVM Biotechnology
    Anika Therapeutics
    Flexion Therapeutics
    OrthoTrophix
    Sanofi
    Horizon Therapeutics
    Johnson and Johnson
    GlaxoSmithKline
    Bayer
    Abbott
    Pfizer
    Buy now